Craythorne, Emma <br/><br/>
Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.  [electronic resource] 

 -  Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology  Sep 2011 
 - 616-20 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-0714 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0714.2011.01017.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adrenal Cortex Hormones--therapeutic use<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antigens, CD20<br/>Drug Administration Schedule<br/>Drug Resistance<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Mouth Diseases--complications<br/>Pemphigus--complications<br/>Rituximab<br/>Severity of Illness Index<br/>Skin Diseases--complications<br/>Treatment Outcome